A kinome-wide selective radiolabeled TrkB/C inhibitor for in vitro and in vivo neuroimaging: synthesis, preclinical evaluation, and first-in-human
The proto-oncogenes NTRK1/2/3 encode the tropomyosin receptor kinases TrkA/B/C which play pivotal roles in neurobiology and cancer. We describe herein the discovery of [11C]-(R)-3 ([11C]-(R)-IPMICF16), a first-in-class positron emission tomography (PET) TrkB/C-targeting radiolabeled kinase inhibitor...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Weitere Verfasser: | |
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Journal of medicinal chemistry
Year: 2017, Jahrgang: 60, Heft: 16, Pages: 6897-6910 |
| ISSN: | 1520-4804 |
| DOI: | 10.1021/acs.jmedchem.7b00396 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1021/acs.jmedchem.7b00396 Verlag, Volltext: https://doi.org/10.1021/acs.jmedchem.7b00396 
|
| Verfasserangaben: | Vadim Bernard-Gauthier, Justin J. Bailey, Andrew V. Mossine, Simon Lindner, Lena Vomacka, Arturo Aliaga, Xia Shao, Carole A. Quesada, Phillip Sherman, Anne Mahringer, Alexey Kostikov, Marilyn Grand’Maison, Pedro Rosa-Neto, Jean-Paul Soucy, Alexander Thiel, David R. Kaplan, Gert Fricker, Björn Wängler, Peter Bartenstein, Ralf Schirrmacher, and Peter J.H. Scott |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1577018664 | ||
| 003 | DE-627 | ||
| 005 | 20220814181329.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180628s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/acs.jmedchem.7b00396 |2 doi | |
| 035 | |a (DE-627)1577018664 | ||
| 035 | |a (DE-576)507018664 | ||
| 035 | |a (DE-599)BSZ507018664 | ||
| 035 | |a (OCoLC)1341012849 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bernard-Gauthier, Vadim |e VerfasserIn |0 (DE-588)1159777292 |0 (DE-627)1022455362 |0 (DE-576)42821732X |4 aut | |
| 245 | 1 | 2 | |a A kinome-wide selective radiolabeled TrkB/C inhibitor for in vitro and in vivo neuroimaging |b synthesis, preclinical evaluation, and first-in-human |c Vadim Bernard-Gauthier, Justin J. Bailey, Andrew V. Mossine, Simon Lindner, Lena Vomacka, Arturo Aliaga, Xia Shao, Carole A. Quesada, Phillip Sherman, Anne Mahringer, Alexey Kostikov, Marilyn Grand’Maison, Pedro Rosa-Neto, Jean-Paul Soucy, Alexander Thiel, David R. Kaplan, Gert Fricker, Björn Wängler, Peter Bartenstein, Ralf Schirrmacher, and Peter J.H. Scott |
| 264 | 1 | |c 2017 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Publication Date (Web): July 11, 2017 | ||
| 500 | |a Gesehen am 28.06.2018 | ||
| 520 | |a The proto-oncogenes NTRK1/2/3 encode the tropomyosin receptor kinases TrkA/B/C which play pivotal roles in neurobiology and cancer. We describe herein the discovery of [11C]-(R)-3 ([11C]-(R)-IPMICF16), a first-in-class positron emission tomography (PET) TrkB/C-targeting radiolabeled kinase inhibitor lead. Relying on extensive human kinome vetting, we show that (R)-3 is the most potent and most selective TrkB/C inhibitor characterized to date. It is demonstrated that [11C]-(R)-3 readily crosses the blood-brain barrier (BBB) in rodents and selectively binds to TrkB/C receptors in vivo, as evidenced by entrectinib blocking studies. Substantial TrkB/C-specific binding in human brain tissue is observed in vitro, with specific reduction in the hippocampus of Alzheimer’s disease (AD) versus healthy brains. We additionally provide preliminary translational data regarding the brain disposition of [11C]-(R)-3 in primates including first-in-human assessment. These results illustrate for the first time the use of a kinome-wide selective radioactive chemical probe for endogenous kinase PET neuroimaging in human. | ||
| 700 | 1 | |a Mahringer, Anne |e VerfasserIn |0 (DE-588)143168827 |0 (DE-627)704409607 |0 (DE-576)335452981 |4 aut | |
| 700 | 1 | |a Fricker, Gert |d 1956- |e VerfasserIn |0 (DE-588)1042227675 |0 (DE-627)768469465 |0 (DE-576)393783464 |4 aut | |
| 700 | 1 | |a soucy, jean-paul |4 oth | |
| 700 | 1 | |a Wängler, Björn |d 1975- |e VerfasserIn |0 (DE-588)129702218 |0 (DE-627)477593909 |0 (DE-576)297793888 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medicinal chemistry |d Washington, DC : ACS, 1959 |g 60(2017), 16, Seite 6897-6910 |h Online-Ressource |w (DE-627)302468846 |w (DE-600)1491411-6 |w (DE-576)090855132 |x 1520-4804 |7 nnas |a A kinome-wide selective radiolabeled TrkB/C inhibitor for in vitro and in vivo neuroimaging synthesis, preclinical evaluation, and first-in-human |
| 773 | 1 | 8 | |g volume:60 |g year:2017 |g number:16 |g pages:6897-6910 |g extent:14 |a A kinome-wide selective radiolabeled TrkB/C inhibitor for in vitro and in vivo neuroimaging synthesis, preclinical evaluation, and first-in-human |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.jmedchem.7b00396 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1021/acs.jmedchem.7b00396 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180628 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 129702218 |a Wängler, Björn |m 129702218:Wängler, Björn |d 60000 |d 62900 |e 60000PW129702218 |e 62900PW129702218 |k 0/60000/ |k 1/60000/62900/ |p 18 | ||
| 998 | |g 1042227675 |a Fricker, Gert |m 1042227675:Fricker, Gert |d 160000 |d 160100 |e 160000PF1042227675 |e 160100PF1042227675 |k 0/160000/ |k 1/160000/160100/ |p 17 | ||
| 998 | |g 143168827 |a Mahringer, Anne |m 143168827:Mahringer, Anne |d 160000 |d 160100 |e 160000PM143168827 |e 160100PM143168827 |k 0/160000/ |k 1/160000/160100/ |p 10 | ||
| 999 | |a KXP-PPN1577018664 |e 3014724602 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"14 S."}],"id":{"doi":["10.1021/acs.jmedchem.7b00396"],"eki":["1577018664"]},"note":["Publication Date (Web): July 11, 2017","Gesehen am 28.06.2018"],"relHost":[{"origin":[{"publisherPlace":"Washington, DC ; Easton, Pa.","dateIssuedDisp":"1959-","publisher":"ACS ; ACS","dateIssuedKey":"1959"}],"recId":"302468846","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 02.10.2020"],"disp":"A kinome-wide selective radiolabeled TrkB/C inhibitor for in vitro and in vivo neuroimaging synthesis, preclinical evaluation, and first-in-humanJournal of medicinal chemistry","id":{"eki":["302468846"],"zdb":["1491411-6"],"issn":["1520-4804"]},"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["American Chemical Society"]},"pubHistory":["1.1959 -"],"language":["eng"],"part":{"volume":"60","year":"2017","text":"60(2017), 16, Seite 6897-6910","issue":"16","pages":"6897-6910","extent":"14"},"title":[{"title":"Journal of medicinal chemistry","title_sort":"Journal of medicinal chemistry"}]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"recId":"1577018664","person":[{"role":"aut","given":"Vadim","display":"Bernard-Gauthier, Vadim","family":"Bernard-Gauthier"},{"family":"Mahringer","role":"aut","given":"Anne","display":"Mahringer, Anne"},{"family":"Fricker","display":"Fricker, Gert","role":"aut","given":"Gert"},{"given":"jean-paul","role":"oth","display":"soucy, jean-paul","family":"soucy"},{"given":"Björn","role":"aut","display":"Wängler, Björn","family":"Wängler"}],"name":{"displayForm":["Vadim Bernard-Gauthier, Justin J. Bailey, Andrew V. Mossine, Simon Lindner, Lena Vomacka, Arturo Aliaga, Xia Shao, Carole A. Quesada, Phillip Sherman, Anne Mahringer, Alexey Kostikov, Marilyn Grand’Maison, Pedro Rosa-Neto, Jean-Paul Soucy, Alexander Thiel, David R. Kaplan, Gert Fricker, Björn Wängler, Peter Bartenstein, Ralf Schirrmacher, and Peter J.H. Scott"]},"title":[{"subtitle":"synthesis, preclinical evaluation, and first-in-human","title":"A kinome-wide selective radiolabeled TrkB/C inhibitor for in vitro and in vivo neuroimaging","title_sort":"kinome-wide selective radiolabeled TrkB/C inhibitor for in vitro and in vivo neuroimaging"}],"language":["eng"]} | ||
| SRT | |a BERNARDGAUKINOMEWIDE2017 | ||